News and Stories About clinical trials

PanCAN takes center stage as president and CEO discusses clinical trials and more.

Editor’s note: In honor of Black History Month, PanCAN is celebrating the contributions of our community’s Black supporters and the […]
READ MORE

Editor’s note: In honor of Black History Month, PanCAN is celebrating the contributions of our community’s Black supporters and the […]
READ MORE

Black Americans are more likely to get pancreatic cancer than any other racial or ethnic group. They have the highest […]
READ MORE

“I can’t believe it. Reesa, of all people…” When Reesa Levy’s friends and family found out she had pancreatic cancer […]
READ MORE

The 2021 Gastrointestinal (GI) Cancers Symposium recently brought together oncologists, researchers, patients and patient advocates, including the Pancreatic Cancer Action […]
READ MORE

Los estudios clinicos han estado en las noticias recientemente porque son la única manera de poder aprobar nuevos tratamientos para […]
READ MORE

A sports quote became the rallying cry for an Ohio teacher and coach fighting pancreatic cancer.

“Life is basically back to normal.” These are the words of five-year stage IV pancreatic cancer survivor, Lynne Holcomb, of […]
READ MORE

Every day in 2021, 166 Americans will learn that they have pancreatic cancer. That’s 60,430 people who are predicted to […]
READ MORE

Editor’s note: January is Pancreatic Cancer Clinical Trials Awareness Month. Today’s article describes the complex and changing landscape of clinical […]
READ MORE

When Mike Donaldson was diagnosed with pancreatic cancer in 2014, he was not yet a father. Now, he and his […]
READ MORE

Editor’s note: January is Pancreatic Cancer Clinical Trials Awareness Month. Today, we kick off the monthlong campaign to bring awareness […]
READ MORE

Get a recap of our World Pancreatic Cancer Day webinar featuring an expert panel discussing the latest in clinical research […]

Adaptive Clinical Trial Design Provides A More Cost Effective, Efficient, and Patient-Centric Approach to Clinical Development Los Angeles, Calif. – […]
READ MORE

We recently announced that our groundbreaking new approach to pancreatic cancer clinical trials – PanCAN’s Precision PromiseSM – is open […]
READ MORE

Adaptive Clinical Trial Design Is More Cost Effective, Patient-Centric and Allows for Faster Learning Than Standard Trials Los Angeles, Calif. […]
READ MORE

“The standard clinical trial system is not working fast enough for pancreatic cancer patients.” — Julie Fleshman, JD, MBA, PanCAN […]
READ MORE

Editor’s note: “Jeopardy!” host Alex Trebek and former Sen. Harry Reid have publicly mentioned being treated with an experimental immunotherapy […]
READ MORE

Editor’s note: Earlier this year, we featured Steven Merlin’s amazing dedication as a Pancreatic Cancer Action Network (PanCAN) volunteer and […]
READ MORE

The Pancreatic Cancer Action Network (PanCAN) recommends clinical trials for pancreatic cancer patients. Right now, though, the coronavirus disease (COVID-19) […]
READ MORE

Editor’s note: Sadly, Adrian Sorrell passed away in June 2020. We are grateful he allowed his story to be shared.  […]
READ MORE

About one in four pancreatic cancer patients have changes in their tumor that suggest certain treatments may work particularly well […]
READ MORE

Editor’s note: This Rare Disease Day, we want to share more about a rare form of pancreatic cancer – pancreatic […]
READ MORE

The American Society of Clinical Oncology (ASCO) released its “Clinical Cancer Advances 2020” report earlier this week – aptly timed […]
READ MORE

Black History Month recognizes and pays tribute to the role African Americans played in shaping U.S. history. While they are […]
READ MORE

“Accelerating Personalized Care” was the theme for the 2020 Gastrointestinal (GI) Cancers Symposium, which took place Jan. 23-25 in San […]
READ MORE

Editor’s note: Sadly, Gina passed away in January 2021. We are so grateful she shared her story to inspire and […]
READ MORE

Editor’s note: January is Pancreatic Cancer Clinical Trials Awareness Month. Throughout the month, we are featuring a “Shedding Light on […]
READ MORE

Editor’s note: January is Pancreatic Cancer Clinical Trials Awareness Month. Today we share the experience of a stage IV pancreatic […]
READ MORE

Editor’s note: During January, Pancreatic Cancer Clinical Trials Awareness Month, we are featuring a “Shedding Light on Clinical Trials” series […]
READ MORE

Editor’s note: Want to be inspired? Keep reading for a new update on Earl Groce, a stage IV pancreatic cancer […]
READ MORE

Editor’s note: January is Pancreatic Cancer Clinical Trials Awareness Month. Throughout the month, we will feature a “Shedding Light on […]
READ MORE

For the first time ever, the five-year survival rate for pancreatic cancer has reached double digits. American Cancer Society’s Cancer […]
READ MORE

Today the U.S. Food and Drug Administration (FDA) approved the targeted therapy Lynparza® (olaparib) for the treatment of patients who […]
READ MORE

Editor’s note: This article kicks off our 2019 Year in Review series – highlighting the research advancements that you – […]
READ MORE

The results from two phase III clinical trials for pancreatic cancer patients were recently announced. Both Lilly’s SEQUOIA and Halozyme’s […]
READ MORE

Clinical trials are necessary to determine whether a drug or treatment combination is safe, effective and an improvement over the […]
READ MORE

When talking to your doctor about pancreatic cancer treatment, it can be hard to know what questions to ask. Developing […]
READ MORE

Cancer immunotherapy involves empowering the patient’s immune system to recognize, attack and destroy cancer cells. While remarkable results have been […]
READ MORE

Every pancreatic tumor – and every pancreatic cancer patient – is different. The Pancreatic Cancer Action Network (PanCAN) strongly recommends […]
READ MORE

This year’s American Society of Clinical Oncology (ASCO) Annual Meeting has brought 40,000 oncologists and other cancer experts from around […]
READ MORE

A new treatment combination – combining chemotherapy and radiation therapy with a common blood pressure drug – has shown promise […]
READ MORE

The morning of Feb. 5, 2016, started like many for Gail. She got up early and headed to the gym […]
READ MORE

The name Earl Groce may sound familiar to you. In January 2018, the then two-and-a-half-year survivor lent his voice during […]
READ MORE

Editor’s Note: In honor of National Minority Health Month, we would like to shed some light on the issues of […]
READ MORE

On April 3, the Pancreatic Cancer Action Network’s (PanCAN) associate director of clinical initiatives, Cassadie Moravek, joined other patient advocacy […]
READ MORE

Editor’s note: In this Washington Post article, Nathaniel Brooks Horwitz wrote about his experience launching biopharmaceutical company Nivien Therapeutics in […]
READ MORE

“There is no way to sugarcoat the fact that pancreatic cancer is very difficult to treat,” begins an article recently […]
READ MORE

It’s African-American History Month, which pays tribute to generations of African-Americans who struggled with adversity to achieve full citizenship in […]
READ MORE

Do you ever see scientific or medical headlines that sound too good to be true? Ask these questions to help […]
READ MORE

The Pancreatic Cancer Action Network’s Patient Central Associates hear many questions and concerns from patients and caregivers about clinical trial […]
READ MORE

A large group of Pancreatic Cancer Action Network (PanCAN) leadership and Scientific and Medical Affairs staff are attending the 2019 […]
READ MORE

Clinical trials are developed to answer certain research questions. To get the right information to answer those questions, a trial […]
READ MORE

Editor’s Note: Because this week is Clinical Trials Awareness Week, we wanted to provide an overview of what the clinical […]
READ MORE

January is National Pancreatic Cancer Clinical Trials Awareness Month. Pancreatic cancer patients who participate in clinical research have better outcomes. […]
READ MORE

Editor’s note: Today’s edition of the 2018 Year in Review series features the 10 most popular news stories on the […]
READ MORE

Editor’s note: Welcome to the first article in our 2018 Year in Review series! Over the next couple weeks, we’ll […]
READ MORE

Editor’s note: Michael Curran, PhD, is a 2018 Pancreatic Cancer Action Network (PanCAN) Translational Research Grant recipient. He is an […]
READ MORE

Editor’s note: Sadly, Gail Bamer died in July 2019. We are grateful to her for allowing her story to be […]
READ MORE

Did you know there are more than 180 different pancreatic cancer clinical trials currently enrolling patients in the United States? […]
READ MORE

We’re sharing a basic overview of clinical trials so you can brush up on your knowledge, get the truth about common misconceptions, […]
READ MORE

Before Allison Lippman of Dallas met her now-husband, she was not convinced she wanted to date anyone. “I was turning […]
READ MORE

It is important to know all your treatment options at every stage of your pancreatic cancer diagnosis. Here are five […]
READ MORE

Editor’s note: You may have heard breakthrough news that came out of the American Society of Clinical Oncology (ASCO) Annual […]
READ MORE

On day four of the American Society of Clinical Oncology (ASCO) Annual Meeting, results of two critically important phase III […]
READ MORE

Editor’s note: April is National Minority Health Month. This blog, entitled “Diverse Patient Participation Crucial for New Treatment Options,” has […]
READ MORE

Editor’s note: Today is National Doctors’ Day, and we are celebrating the critical roles of various specialists in the diagnosis […]
READ MORE

In June 2014, David Wingo went to his doctor about abdominal pain. While investigating the pain, his doctor noticed a […]
READ MORE

Pancreatic cancer patients who participate in clinical research have better outcomes. Every treatment available today was approved through a clinical trial. […]
READ MORE

“All Cancer Patients Should Have Access To Genomic Testing” is the title of a compelling article featured in Forbes earlier […]
READ MORE

The 2nd International Congress on Clinical Trials in Oncology and Hemato-Oncology (ICTO2018) took place earlier this week in Berlin. The […]
READ MORE

The Pancreatic Cancer Action Network (PanCAN) is excited to launch Precision PromiseSM in 2019. Precision Promise is the first adaptive […]
READ MORE

Today, the U.S. Food & Drug Administration (FDA) approved Lutathera® (lutetium-177 (177Lu)-Dotatate) for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs), […]
READ MORE

In September 2015, Earl Groce returned home to North Carolina after driving 5,500 miles cross-country for his first trip to […]
READ MORE

One of the most important topics of conversation around clinical trials is patient participation. When looking at the national enrollment […]
READ MORE

The Pancreatic Cancer Action Network Urges All Pancreatic Cancer Patients to Consider Clinical Trial Enrollment Pancreatic Cancer Patients Who Participate […]
READ MORE

Richard Blish, a nine-year pancreatic cancer survivor, was diagnosed in 2009 with a marginally resectable tumor and less than a […]
READ MORE

This year during National Pancreatic Cancer Clinical Trials Awareness Month, we Demand Better. For Patients. For Survival. Matt Wilson, a […]
READ MORE

January is National Pancreatic Cancer Clinical Trials Awareness Month. Thanks to the community’s participation last year, the Pancreatic Cancer Action […]
READ MORE

At the end of every year, Science magazine announces a Breakthrough of the Year – a discovery that revolutionized the […]
READ MORE

Choosing a clinical trial on your own can be challenging. Some trial listings are out-of-date, and others require looking through […]
READ MORE

Published in the Journal of Gastrointestinal Cancer, a recent survey of 150 oncologists showed a lack of compliance with evidence-based […]
READ MORE

Pancreatic cancer is difficult to treat. There are a few standard treatments, but there are additional options that we encourage […]
READ MORE

An article published yesterday in Newsweek describes a European analysis that found cancer drugs are being approved without adequate evidence […]
READ MORE

A pancreatic cancer diagnosis and the decisions that come after can feel overwhelming. But getting organized can help patients and […]
READ MORE

A news article originally published in USA Today explored the relatively low number of Hispanics who enroll in clinical trials […]
READ MORE

The so-called breast cancer genes BRCA1 and BRCA2 were originally found to increase a woman’s risk of breast cancer when […]
READ MORE

The final episode of a three-part documentary, First in Human, aired on Aug. 24, on Discovery. The six-hour series provided a […]
READ MORE

The second episode of the three-part Discovery documentary on clinical trials, First in Human, follows the gripping story of three […]
READ MORE

The first episode of a three-part documentary, First in Human, debuted Aug. 10, on Discovery. The six-hour series provides a […]
READ MORE

Clinical trials are critical to advance treatment options, and pancreatic cancer patients who participate in clinical research have better outcomes. […]
READ MORE

Editor’s note: Keytruda was the first cancer drug approved to treat any solid tumor – anywhere in the body – […]
READ MORE

In 2009, Jennifer Tseng, MD, and her team were scouring a National Cancer Institute’s (NCI) Surveillance, Epidemiology, and End results […]
READ MORE

CBS “Sunday Morning” aired a special titled, “Beyond Cancer,” featuring the latest news on research, diagnosis and treatments, plus stories […]
READ MORE

Meet Vincent Picozzi, Jr., MD, director of the pancreaticobiliary program at the Floyd & Delores Jones Cancer Institute at Virginia […]
READ MORE

The online healthcare publisher OncLive often features interviews with doctors and researchers who specialize in pancreatic cancer. This week they […]
READ MORE

Throughout National Pancreatic Cancer Clinical Trials Awareness Month, you’ve received a lot of information. We’ve shared firsthand survivor stories, provided […]
READ MORE

Pancreatic cancer patients who participate in clinical research have better outcomes. Every treatment available today was approved through a clinical […]
READ MORE

Making treatment decisions may be overwhelming. We want to make sure you have the information you need, every step of […]
READ MORE

Why do people not participate in clinical trials? Some assume it’s a scary process involving being “experimented on” like you […]
READ MORE

Pancreatic cancer patients who participate in clinical research have better outcomes. Every treatment available today was approved through a clinical […]
READ MORE

It can be difficult to keep track of the different treatment options available for pancreatic cancer, and many patients are […]
READ MORE

Olympians aren’t the only people taking home medals. We are proud to have won bronze for our Clinical Trial Finder […]
READ MORE

Fighting pancreatic cancer is no easy task. That’s why the Pancreatic Cancer Action Network is excited to join forces with […]
READ MORE

A rigorous analysis of 25 years’ worth of pancreatic cancer clinical trial data was published on June 6, 2016, in […]
READ MORE

Preliminary results from an early-phase immunotherapy clinical trial suggest that an innovative treatment could be effective for patients with locally-advanced or borderline-resectable pancreatic cancer.

Pancreatic Cancer Patients Encouraged to Consider Clinical Trial Enrollment MANHATTAN BEACH, Calif. – (January 6, 2016) — With no effective screening […]
READ MORE